Abstract Coagulopathy in acute promyelocytic leukemia (APL) is a very complex disorder and is believed to result from interplay of various factors. Usually patients present with bleeding tendencies which can be life threatening. However, a few present with thromboses. Here, we report a young male with APL who presented with ischemic stroke in young.
/l. Peripheral smear showed more than 90% abnormal hypergranular promyelocytes ( Fig. 1 ). Blood chemistry was essentially normal. Coagulation profile revealed deranged prothrombin time (18 s with control of 12 s) with normal activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen levels. D-Dimer levels were raised. Urgent noncontrast CT scan of the head was carried out which showed a hypodense area suggestive of infarct in the right parietooccipital region along with cerebral edema (Fig. 2) . ECG showed sinus tachycardia with T wave inversion in anterior and lateral leads. Troponin (T) was negative. On the basis of peripheral smear findings and clinical presentation, the patient was immediately started on all-trans-retinoic acid (ATRA) at a dose of 45 mg/m 2 . As he presented in Sanz high risk category with very high TLC, ATRA was followed by parenteral daunorubicin at dose of 60 mg/m 2 . Blood component support with fresh frozen plasma, platelet concentrates, and packed RBC was given along with mannitol as the cerebral decongestant. Bone marrow examination done subsequently showed replacement by abnormal hypergranular promyelocytes with strong cytochemical positivity for myeloperoxidase (MPO) and sudan black (SBB) stains compatible with diagnosis of acute promyelocytic leukemia (APL) (Fig. 2) . Immunophenotyping revealed positivity for CD 13, CD 33, CD 34, anti-MPO and negativity for HLA-DR, CD 2, CD 7, CD 79a, CD 117, and CD 19 in these cells. Coexpression of CD 10 was also noted. The diagnosis of APL was confirmed by positivity for PML-RARa (promyelocytic leukemia-retinoic acid receptor alpha) fusion transcript by reverse-transcription-polymerase chain reaction (RT-PCR). However, his condition continued to deteriorate. A repeat CT scan performed on day 3 revealed significant increase in infarct size. The patient lapsed into deep coma and finally expired on 4th day.
Discussion
Acute promyelocytic leukemia is a subtype of acute myelogenous leukemia characterized by characteristic abnormal hypergranular promyelocytes in peripheral blood and bone marrow [1] . It typically presents with life threatening hemorrhagic diathesis which worsens with cytotoxic chemotherapy. Coagulopathy in APL is a very complex disorder and is believed to result from interplay of three main factors [2] . Firstly, there is activation of extrinsic pathway secondary to release of tissue factor and cancer pro-coagulant from malignant cells. Secondly, there is increased annexin II receptor expression on the surface of the leukemic promyelocytes [3] . Annexin II receptor binds plasminogen and tissue plasminogen activator and increases plasmin formation by a factor of 60, thereby leading to increased WBC white blood cell, DVT deep vein thrombosis, PE pulmonary embolism, NR not recorded, MI myocardial infarction, RV right ventricle fibrinolysis. Thirdly, there is increased non-specific proteolysis leading to increased bleeding tendency [2] . Though bleeding tendencies are the more common presentation in APL, prothrombotic state is also seen in APL [4] . Paradoxically ATRA which induces complete remission in majority of cases and rapidly reverses coagulopathy has been implicated in prothrombotic state [5] . In two large scale studies incidence of thrombosis has varied from 4.5 to 5.6% [6, 7] . Table 1 summarizes clinical details of patients of APL presenting with thrombosis. Postulated mechanisms include release of cytokines subsequent to initiation of treatment [2] and rapid correction of fibrinolysis by ATRA inducing a prothrombotic state [6] . A high TLC, bcr3 (short) isoform of PML-RARa transcripts, FLT3 ITD, expression of CD 2 and CD 15 on leukemic cells have been found to be associated with increased risk of thrombosis [7] . Our patient had presented with ischemic infarct before initiation of any treatment which makes it a rare presentation. Almost any organ can be affected with thrombosis. There are case reports of patients presenting with acute myocardial infarction and also ischemic stroke [7] [8] [9] . Rarely presentation may be with acute Budd-Chiari syndrome [10] . Presentation with thrombotic event portends a poor prognosis as was seen in our patient. Additional mechanisms predisposing to prothrombotic state besides ATRA need to be further elucidated in similar cases.
